ShareValue scores for 603014.SHG: Valuation 60, Quality 57, Growth 50, Health 63.

603014.SHG
SSE

Shandong Weigao Blood

CN¥34.19(+0.71%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 17%
Valuation
60
Fair Value
Price vs Value
Quality
57
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
63
Moderate
Financial Stability
Momentum
26
Bearish
Price Trend

Company Details

About

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers; dialysis machines; hemodialysis tubing, products, and machines; peritoneal dialysis products; dialysis supporting products, such as hemoperfusion devices, dialysis powder and liquid, puncture needles, and iodine caps for peritoneal dialysis. The company was founded in 2004 and is based in Weihai, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026